According to a recent study, one in eight men develop prostate cancer at some point during their life.
Government figures show that this is the most common cancer among men in England, with 34,900 new cases diagnosed in 2010, accounting for 26 percent of all new occurrences of cancer in males, the Daily Express reported.
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/300x250/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is commonly used to diagnose prostate cancer.
Advertisement
This equates to 106 new cases per 100,000, according to the Office for National Statistics.
That is down slightly from 2009, when 110 new cases per 100,000 men were recorded, but it is still the second highest rate in more than 40 years.
![Prostate Cancer Screening]( "Prostate Cancer Screening")
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.
In 2010, 75 percent of the new cases were in men aged 65 and over, with the largest number in the 70 to 74 age bracket.
Sir Roger Moore, at the age of 65 in 1993, faced one of his worst fears when he discovered he had the disease. The movie actor, now 85, made a full recovery.
Prostate cancer is the second most common cause of male cancer deaths after lung cancer, causing 13 percent of fatalities.
But despite the rising number of men being diagnosed with the disease, it is killing less - with the mortality rate dropping since 1992.
Death rates had been increasing steadily until then from 1971.
Experts claim the figures are a result of advances in testing and treatment.
Of those diagnosed between 2006 and 2011, 80 percent survived for five years compared to 75 percent of those diagnosed between 1999 and 2004.
Unlike most forms of cancer, younger patients are more likely to die from prostate cancer.
Men aged 15 to 48 have a 90 per cent chance of survival while those 50 to 69 have a 92 per cent chance.
Source: ANI
Prostate Cancer Screening
PSA (Prostate Specific Antigen) test and Digital Rectal Examination are two tests that allow detection of prostate cancer at early stages.
Advertisement
In 2010, 75 percent of the new cases were in men aged 65 and over, with the largest number in the 70 to 74 age bracket.
Sir Roger Moore, at the age of 65 in 1993, faced one of his worst fears when he discovered he had the disease. The movie actor, now 85, made a full recovery.
Prostate cancer is the second most common cause of male cancer deaths after lung cancer, causing 13 percent of fatalities.
But despite the rising number of men being diagnosed with the disease, it is killing less - with the mortality rate dropping since 1992.
Death rates had been increasing steadily until then from 1971.
Experts claim the figures are a result of advances in testing and treatment.
Of those diagnosed between 2006 and 2011, 80 percent survived for five years compared to 75 percent of those diagnosed between 1999 and 2004.
Unlike most forms of cancer, younger patients are more likely to die from prostate cancer.
Men aged 15 to 48 have a 90 per cent chance of survival while those 50 to 69 have a 92 per cent chance.
Source: ANI
Quiz on Prostate Cancer
Prostate cancer is fast gaining as a common cancer form among men; more threatening since its symptoms often go unnoticed until it's too late. This quiz tests your knowledge on prostate cancer, its diagnosis and treatment options and is as mandatory for men as the screening tests mentioned here are!
Advertisement
 | Advertisement
|
Advertisement
Recommended Readings
Latest Menīs Health News
Prostate cancer mutations targeting PI3K signaling are greatly influenced by PLEKHS1, a protein, enhances cancer drug therapy efficiency.
A substantial reduction in mortality risk was found in older men taking medications for lower urinary tract symptoms (LUTS).
Men's human papillomavirus (HPV) infections underscore the importance of their participation in efforts to reduce HPV-related diseases in all genders.
Men who received active Optilume treatment demonstrated more significant improvement in symptoms related to benign prostatic hyperplasia.
Investigation of sperm formation and its molecular intricacies reveals a potential connection between infertility and alterations in sperm amino acids.
